U.S. Anesthesia Partners Signs Three-Year Agreement with Cigna HealthCare of Florida, Inc.

Published on February 10, 2021

Preserves in-network access to high-quality anesthesia care for Cigna members while incorporating innovative pay-for-performance and patient care quality…

Continue reading on website
Other news

Abzena selected by Immunome to develop and manufacture antibody cocktail for Immunome’s COVID-19 Antibody Based Treatment

February 3, 2021
Exton, PA and San Diego, CA – February 3, 2021 – Immunome, Inc. (Nasdaq: IMNM), a biopharmaceutical company utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics, and Abzena, a partner research organization for integrated discovery to cGMP manufacturing solutions for biologics, today announced that Abzena was selected as Immunome’s partne

U.S. Anesthesia Partners Signs Three-Year Agreement with Cigna HealthCare of Florida, Inc.

February 10, 2021
U.S. Anesthesia Partners Signs Three-Year Agreement with Cigna HealthCare of Florida, Inc. diana_carranzaWed, 02/10/2021 - 15:53Read more about U.S. Anesthesia Partners Signs Three-Year Agreement with Cigna HealthCare of Florida, Inc.